Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
Psychiatric Laboratory and Mental Health Center, The State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, China.
Mov Disord. 2021 Sep;36(9):2077-2084. doi: 10.1002/mds.28621. Epub 2021 Apr 21.
Age at onset (AAO) is an essential feature of Parkinson's disease (PD) and can help predict disease progression and mortality. Identification of genetic variants influencing AAO of PD could lead to a better understanding of the disease's biological mechanism and provide clinical guidance. However, genetic determinants for AAO of PD remain mostly unknown, especially in the Asian population.
To identify genetic determinants for AAO of PD in the Asian population.
We performed a genome-wide association meta-analysis on AAO of PD in 5166 Chinese patients with PD (N = 3628, N = 1538). We then conducted a further cross-ethnic meta-analysis using our results and summary statistics for the AAO of PD from the European population.
The total heritability of AAO of PD was around 0.10 ~ 0.14, similar to that (0.11) estimated in populations of European ancestry. One novel significant intergenic locus rs9783733 (NDN; PWRN4) was identified (P = 3.14E-09, beta = 2.30, SE = 0.39). Remarkably, this variant could delay AAO of PD by ~2.43 years, with a more considerable effect on males (3.18 years) than females (~1.45 years). The variant was suggestively significant in the cross-ethnic meta-analysis and suggested a positive selection in the East Asian population. Additionally, cross-ethnic meta-analysis identified a significant locus rs356203 in SNCA (P = 2.35E-11, beta = -0.71, SE = 0.01).
These findings improve the current understanding of the genetic etiology of AAO of PD in different ethnic groups, and provide a new target for further research on PD pathogenesis and potential therapeutic options. © 2021 International Parkinson and Movement Disorder Society.
发病年龄(AAO)是帕金森病(PD)的一个重要特征,有助于预测疾病进展和死亡率。确定影响 PD AAO 的遗传变异可以帮助我们更好地了解疾病的生物学机制,并为临床提供指导。然而,PD AAO 的遗传决定因素在很大程度上仍然未知,尤其是在亚洲人群中。
鉴定亚洲人群 PD AAO 的遗传决定因素。
我们对 5166 名中国 PD 患者的 PD AAO 进行了全基因组关联荟萃分析(N=3628,N=1538)。然后,我们使用我们的结果和欧洲人群 PD AAO 的汇总统计数据进行了进一步的跨种族荟萃分析。
PD AAO 的总遗传率约为 0.100.14,与欧洲人群(0.11)估计的遗传率相似。鉴定出一个新的显著的基因间位点 rs9783733(NDN;PWRN4)(P=3.14E-09,β=2.30,SE=0.39)。值得注意的是,该变异可使 PD AAO 延迟约 2.43 年,对男性(3.18 年)的影响大于女性(1.45 年)。该变异在跨种族荟萃分析中具有提示意义,并表明其在东亚人群中受到正向选择。此外,跨种族荟萃分析鉴定出 SNCA 中的显著位点 rs356203(P=2.35E-11,β=-0.71,SE=0.01)。
这些发现提高了我们对不同种族群体 PD AAO 遗传病因的认识,并为进一步研究 PD 发病机制和潜在治疗选择提供了新的靶点。© 2021 国际帕金森病和运动障碍学会。